Winton Capital’s David Harding on making millions through maths

The founder of the $32bn hedge fund talks about physics, philanthrophy and why he believes in tax

Interview: Joanna Scanlan, one of Britain’s great comic actors

Despite starring roles in ‘The Thick of It’, ‘Getting On’ and ‘No Offence’, her path to the top has been far from smooth

Chrystel Lebas photographs the British landscape

Following in the footsteps of Edward James Salisbury, the French photographer reveals the changes wrought by climate and man

The lingering legacy of apartheid

‘Black lives in South Africa are improving but most middle-class blacks are one mis-step away from calamity’

Photo of Simon Kuper

Why forecasters failed to predict Trump’s victory

‘Confident, eye-catching forecasts are the snack food of analysis and commentary’

‘Shy’ voters: the secret of Trump’s success

‘A vote for Trump was like eating ice-cream laced with whisky for breakfast — something people did not want to admit to’

Photo of Gillian Tett

‘Hamilton’ and the rise of muscular thespianism

‘The fightback against Donald Trump will only be won in a relentless and gruelling battle’

Photo of Robert Shrimsley

FT Masterclass: Rediscovering ‘The Crystal Maze’

The cult 1990s game show lives again, allowing fans to don a bomber jacket, lose their inhibitions and, just maybe, earn enough golden tokens to make a childhood dream come true

‘I shoot films in abandoned buildings’

Director Ben Lambert on how these spaces become characters in the films

Inside British Cycling’s medal factory

Britain has dominated the Olympic sport. But as allegations of doping and bullying swirl, can the team do it again? 

High stakes: Eli Lilly’s hunt for an Alzheimer’s drug

On Wednesday, the pharma giant learnt that Sola — a drug it hoped would slow the progression of the disease — had failed its phase III trial. Before that, David Crow reported on the company’s long search for a cure

Latest in FT Magazine

Video